medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 9.89
+0.06 (0.61%)
Oct 2, 2026, 5:30 PM CET
medmix AG Ratios and Metrics
Market cap in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 403 | 459 | 359 | 777 | 720 | 1,863 | |
Market Cap Growth | 10.32% | 27.82% | -53.78% | 7.85% | -61.36% | - |
Enterprise Value | 618 | 677 | 592 | 941 | 856 | 2,262 |
Last Close Price | 9.89 | 11.12 | 8.28 | 17.30 | 15.65 | 39.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4025.84 | 71.69 | - | 2588.86 | 62.08 | 42.35 |
Forward PE | 19.51 | 24.57 | 12.90 | 15.32 | 12.43 | 26.58 |
PS Ratio | 0.92 | 1.02 | 0.74 | 1.60 | 1.51 | 4.08 |
PB Ratio | 0.93 | 1.06 | 0.80 | 1.64 | 1.43 | 3.49 |
P/TBV Ratio | 6.60 | 8.22 | 7.46 | 11.06 | 5.49 | 13.17 |
P/FCF Ratio | 12.70 | 13.78 | 7.46 | 80.07 | 64.29 | 32.41 |
P/OCF Ratio | 6.79 | 6.77 | 4.14 | 13.84 | 15.13 | 21.35 |
PEG Ratio | - | 0.61 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.42 | 1.51 | 1.22 | 1.93 | 1.79 | 4.95 |
EV/EBITDA Ratio | 7.64 | 9.29 | 8.70 | 15.47 | 10.67 | 21.55 |
EV/EBIT Ratio | 21.40 | 23.36 | 30.83 | 54.37 | 20.98 | 36.03 |
EV/FCF Ratio | 19.51 | 20.34 | 12.30 | 96.97 | 76.42 | 39.35 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.74 | 0.77 | 0.74 | 0.74 | 0.94 | 0.60 |
Debt / EBITDA Ratio | 3.94 | 4.06 | 4.20 | 5.01 | 5.34 | 2.86 |
Debt / FCF Ratio | 10.08 | 10.04 | 6.84 | 36.28 | 42.28 | 5.58 |
Net Debt / Equity Ratio | 0.48 | 0.51 | 0.47 | 0.47 | 0.31 | 0.21 |
Net Debt / EBITDA Ratio | 2.91 | 3.03 | 3.10 | 3.64 | 1.95 | 1.06 |
Net Debt / FCF Ratio | 6.57 | 6.62 | 4.39 | 22.81 | 13.99 | 1.93 |
Asset Turnover | 0.45 | 0.47 | 0.49 | 0.46 | 0.46 | 0.52 |
Inventory Turnover | 3.44 | 3.83 | 3.96 | 3.65 | 3.56 | 3.88 |
Quick Ratio | 1.08 | 1.02 | 1.04 | 1.11 | 1.41 | 2.11 |
Current Ratio | 1.52 | 1.54 | 1.60 | 1.73 | 1.80 | 2.89 |
Return on Equity (ROE) | 0.21% | 1.59% | -1.39% | 0.14% | 2.23% | 10.15% |
Return on Assets (ROA) | 1.88% | 1.90% | 1.22% | 1.02% | 2.45% | 4.44% |
Return on Invested Capital (ROIC) | 2.90% | 3.48% | 2.84% | 0.61% | 5.94% | 8.31% |
Return on Capital Employed (ROCE) | 3.70% | 3.70% | 2.40% | 2.10% | 4.90% | 7.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.02% | 1.40% | -2.06% | 0.04% | 1.61% | 2.36% |
FCF Yield | 7.87% | 7.26% | 13.40% | 1.25% | 1.55% | 3.09% |
Dividend Yield | 1.01% | 0.90% | 6.04% | 2.89% | 3.20% | 1.26% |
Payout Ratio | 8700.00% | 234.38% | - | 5000.00% | 129.31% | 93.86% |
Buyback Yield / Dilution | -12.25% | -0.24% | -0.50% | -0.25% | 0.15% | -20.14% |
Total Shareholder Return | -11.23% | 0.66% | 5.54% | 2.64% | 3.35% | -18.87% |